We are live on ! Find out more
CCM

Cadence Capital Management Portfolio holdings

AUM $415M
1-Year Est. Return 11.01%
This Fund
S&P 500
This Quarter Est. Return
+4.03%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
AUM
$1.6B
AUM Growth
+$156M
Cap. Flow
+$97.6M
Cap. Flow %
6.11%
Top 10 Hldgs %
9.41%
Holding
763
New
106
Increased
302
Reduced
233
Closed
107

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$8.8M
2
VLO icon
Valero Energy
VLO
+$6.69M
3
XRX icon
Xerox
XRX
+$6.11M
4
META icon
Meta Platforms (Facebook)
META
+$5.7M
5
VFC icon
VF Corp
VFC
+$5.57M

Sector Composition

Rank Sector Weight
1 Energy 17.1%
2 Financials 12.37%
3 Healthcare 12.35%
4 Consumer Staples 11.92%
5 Industrials 11.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPD icon
1
Enterprise Products Partners
EPD
$83.8B
$18M 1.13%
+690,482
New +$18.3M
MMP
2
DELISTED
Magellan Midstream Partners, L.P.
MMP
$16.5M 1.03%
+232,698
New +$16.1M
OKE icon
3
Oneok
OKE
$58.7B
$15.2M 0.95%
274,895
+238,092
+647% +$12.9M
XOM icon
4
ExxonMobil
XOM
$651B
$15.1M 0.94%
183,663
+12,270
+7% +$974K
CVX icon
5
Chevron
CVX
$388B
$15M 0.94%
127,510
-3,564
-3% -$389K
SLB icon
6
SLB Ltd
SLB
$77.8B
$14.8M 0.92%
211,550
+53,911
+34% +$3.56M
JPM icon
7
JPMorgan Chase
JPM
$939B
$14.3M 0.89%
149,845
-29,736
-17% -$2.74M
WFC icon
8
Wells Fargo
WFC
$261B
$14.1M 0.88%
256,410
-11,631
-4% -$618K
VZ icon
9
Verizon
VZ
$194B
$13.8M 0.86%
278,209
+6,243
+2% +$294K
T icon
10
AT&T
T
$165B
$13.7M 0.86%
464,361
+34,542
+8% +$981K
BA icon
11
Boeing
BA
$165B
$13.7M 0.86%
53,921
-17,171
-24% -$4M
GILD icon
12
Gilead Sciences
GILD
$161B
$13.6M 0.85%
168,324
+11,825
+8% +$904K
ABBV icon
13
AbbVie
ABBV
$458B
$13.6M 0.85%
153,190
-28,849
-16% -$2.2M
JNJ icon
14
Johnson & Johnson
JNJ
$635B
$13.6M 0.85%
104,659
-8,381
-7% -$1.11M
CSCO icon
15
Cisco
CSCO
$450B
$13.6M 0.85%
403,533
+1,847
+0.5% +$58.8K
INTC icon
16
Intel
INTC
$466B
$13.6M 0.85%
356,073
-21,815
-6% -$775K
PFE icon
17
Pfizer
PFE
$140B
$13.4M 0.84%
396,059
+19,717
+5% +$634K
BMY icon
18
Bristol-Myers Squibb
BMY
$127B
$13.4M 0.84%
210,235
+15,803
+8% +$923K
AMGN icon
19
Amgen
AMGN
$203B
$13.4M 0.84%
71,731
-3,186
-4% -$565K
ET icon
20
Energy Transfer Partners
ET
$70.1B
$13.4M 0.84%
+768,468
New +$13.4M
PM icon
21
Philip Morris
PM
$301B
$13.3M 0.83%
120,244
+7,233
+6% +$842K
WMT icon
22
Walmart Inc
WMT
$871B
$13.3M 0.83%
511,401
+14,457
+3% +$379K
QCOM icon
23
Qualcomm
QCOM
$176B
$13.2M 0.83%
255,475
+67,186
+36% +$3.55M
MO icon
24
Altria Group
MO
$122B
$13.2M 0.82%
207,869
+60,919
+41% +$4.06M
MRK icon
25
Merck
MRK
$324B
$13.1M 0.82%
214,953
+13,143
+7% +$797K

Similar funds

Cadence Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Cadence Capital Management held 763 positions worth $1.6B, up 11% from $1.44B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Cadence Capital Management deployed $97.6M of net new capital in Q3 2017, opening 106 new positions and adding to 302 existing holdings. Its largest new stake was Enterprise Products Partners: 690,482 shares worth $18M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 7.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Valero Energy, an estimated $6.69M trimmed.

  • Cadence Capital Management's largest Q3 2017 buy was Enterprise Products Partners: 690,482 shares worth $18M.
  • Cadence Capital Management added most to Oneok in Q3 2017, an estimated $12.9M increase.
  • Cadence Capital Management's biggest Q3 2017 reduction was Valero Energy, cutting an estimated $6.69M.
  • Cadence Capital Management fully exited Abbott in Q3 2017, selling an estimated $8.8M.
  • Cadence Capital Management's ten largest holdings make up 9.4% of its $1.6B portfolio in Q3 2017.
  • Cadence Capital Management opened 106 new positions and closed 107 in Q3 2017.
  • Cadence Capital Management's portfolio value rose 11% quarter-over-quarter to $1.6B.

Based on Cadence Capital Management's 13F filing for Q3 2017, filed 9 Nov 2017.